Discontinued — last reported Q4 '25
IQVIA Contract Sales & Medical Solutions — Revenue increased by 0.5% to $210.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.6%, from $177.00M to $210.00M. Over 4 years (FY 2021 to FY 2025), Contract Sales & Medical Solutions — Revenue shows relatively stable performance with a 0.1% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates higher demand for outsourced commercialization services, while a decrease suggests reduced client spending or contract losses.
This metric represents the total gross income generated by the contract sales and medical solutions business unit. It re...
Similar to revenue metrics for commercial outsourcing divisions at other global contract research organizations.
iqv_segment_contract_sales_medical_solutions_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $194.00M | $201.00M | $196.00M | $195.00M | $183.00M | $183.00M | $182.00M | $182.00M | $176.00M | $183.00M | $186.00M | $189.00M | $172.00M | $180.00M | $177.00M | $181.00M | $188.00M | $209.00M | $210.00M |
| QoQ Change | — | +3.6% | -2.5% | -0.5% | -6.2% | +0.0% | -0.5% | +0.0% | -3.3% | +4.0% | +1.6% | +1.6% | -9.0% | +4.7% | -1.7% | +2.3% | +3.9% | +11.2% | +0.5% |
| YoY Change | — | — | — | — | -5.7% | -9.0% | -7.1% | -6.7% | -3.8% | +0.0% | +2.2% | +3.8% | -2.3% | -1.6% | -4.8% | -4.2% | +9.3% | +16.1% | +18.6% |